Riik: Iirimaa
keel: inglise
Allikas: HPRA (Health Products Regulatory Authority)
Mometasone furoate
LTT Pharma Limited
R01AD; R01AD09
Mometasone furoate
50 microgram(s)
Nasal spray, suspension
Product subject to prescription which may not be renewed (A)
Corticosteroids; mometasone
Authorised
2016-09-02
PLEASE READ THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET What Nasonex is and what it is used for What you need to know before you use Nasonex How to use Nasonex Possible side effects How to store Nasonex Contents of the pack and other information WHAT NASONEX IS AND WHAT IT IS USED FOR WHAT IS NASONEX? Nasonex Nasal Spray contains mometasone furoate, one of a group of medicines called corticosteroids. When mometasone furoate is sprayed into the nose, it can help to relieve inflammation (swelling and irritation of the nose), sneezing, itching and a blocked up or runny nose. WHAT IS NASONEX USED FOR? Hayfever and perennial rhinitis Nasonex is used to treat the symptoms of hayfever (also called seasonal allergic rhinitis) and perennial rhinitis in adults and children aged 3 and older. Hayfever, which occurs at certain times of the year, is an allergic reaction caused by breathing in pollen from trees, grasses, weeds and also moulds and fungal spores. Perennial rhinitis occurs throughout the year and symptoms can be caused by a sensitivity to a variety of things including house dust mite, animal hair (or dander), feathers and certain foods. Nasonex reduces the swelling and irritation in your nose and thereby relieving sneezing, itching and a blocked-up or runny nose caused by hayfever or perennial rhinitis. Nasal polyps Nasonex is used to treat nasal polyps in adults aged 18 and over. Nasal polyps are small growths on the lining of the nose and usually affect both nostrils. Nasonex reduces the inflammation in the nose, ca Lugege kogu dokumenti
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Nasonex 50 micrograms/actuation Nasal Spray, Suspension 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Mometasone furoate (as the monohydrate) 50 micrograms/actuation. Excipient with known effect: This medicinal product contains benzalkonium chloride. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Nasal Spray, Suspension. Product imported from Greece White to off-white opaque suspension. 4 CLINICAL PARTICULARS As per PA1286/038/001 5 PHARMACOLOGICAL PROPERTIES As per PA1286/038/001 6 PHARMACEUTICAL PARTICULARS 6.1 LIST OF EXCIPIENTS dispersible cellulose (microcrystalline cellulose and sodium carmellose) glycerol sodium citrate citric acid monohydrate polysorbate 80 benzalkonium chloride purified water 6.2 INCOMPATIBILITIES Not applicable. 6.3 SHELF LIFE The shelf life expiry date for this product is the date shown on the bottle and outer package of the product as marketed in the country of origin. Use within 2 months of first use. H E A L T H P R O D U C T S R E G U L A T O R Y A U T H O R I T Y ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ _D_ _a_ _t_ _e_ _ _ _P_ _r_ _i_ _n_ _t_ _e_ _d_ _ _ _2_ _7_ _/_ _0_ _7_ _/_ _2_ _0_ _1_ _7_ _C_ _R_ _N_ _ _ _2_ _1_ _9_ _5_ _2_ _8_ _8_ _p_ _a_ _g_ _e_ _ _ _n_ _u_ _m_ _b_ _e_ _r_ _:_ _ _ _1_ 6.4 SPECIAL PRECAUTIONS FOR STORAGE Do not store above 25°C. Do not freeze. 6.5 NATURE AND CONTENTS OF CONTAINER NASONEX Nasal Spray is contained in a white bottle, that contains 18 g (140 actuations) of product formulation, supplied with a metered-dose, manual spray pump actuator. Lugege kogu dokumenti